BIOsens
PrivateLast Round
Grant
Jun 10, 2020
Total Funding Raised
$81,000
Company Overview
BIOsens is a biotechnology company that develops portable diagnostic devices for rapid mycotoxin detection in food and agricultural products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Sensors, Environmental Monitoring
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BIOsens Comparables
Compare BIOsens with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ExciPlex | 87% | |
| Aflabox | 85% | |
| RapidBio Systems, Inc. | 83% | |
BIOsens Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 10, 2020 | ||||
| Accelerator | Oct 3, 2019 | ||||
| Grant | Apr 1, 2019 | ||||
| Accelerator | Nov 17, 2017 |
BIOsens Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Monthly visitors grew 169% MoM to 2.1K.
- May 1, 2025
Monthly visitors increased 58% MoM.
BIOsens Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BIOsens's valuation, stock price, and market status.